Sensitivity profiles correlated strongly with profiles of multiple inhibitors of the AKT/mTOR pathway, particularly in mutant KRAS NSCLC lines, suggesting a mechanistic interaction between TBK1 and the mTOR pathway (134). This evidence concerns the gene KRAS and non-small cell lung carcinoma.